Responses
ePoster Viewing
AS11. Ovarian cancer
EP267/#913 Monitoring of minimal residual disease with circulating tumor DNA in patients with epithelial ovarian cancer on long-term PARP inhibitor maintenance therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.